Registering a CAGR of 8.6% over the forecast period, the breast biopsy devices market is anticipated to reach the market value of US$ 1,094 million in the year 2027 from US$ 725 million in the year 2022
When there is suspicion that the lump is filled with fluid, fine-needle biopsies are performed. The lump fluid is drawn out is discarded. During a core needle biopsy, with the help of a needle that has a larger core, a small amount of suspicious tissue is removed from the breast. In the majority of cases, specialized imaging equipment is used in order to guide the needle to the desired site. There are several types of equipment used for this procedure such as magnetic resonance, ultrasound equipment, or stereotactic equipment.
As far as revenue is concerned, North America is the leading contributor in the market. Helping the expansion of the market, the number of biopsies performed in the US is found to be the highest. It is expected that sophisticated healthcare infrastructure and the growing pervasiveness of infections will positively impact the market over the forecast period.
The increasing incidences of breast cancer among the female population across the globe acts as one of the major factors driving the growth of the breast biopsy devices market. The rise in the number of breast cancer screening programs owning to government efforts and increase in demand for minimally invasive and non-invasive procedures because of its various advantages such as fast recovery and less pain accelerate the market growth. The growth in awareness regarding early detection of breast cancer and the improved reimbursement scenario further influence the market growth. Additionally, rise in population, the surge in healthcare expenditure, and the rise in initiatives by public organizations towards female health problems positively affect the breast biopsy devices market. Furthermore, the emergence of liquid biopsy and promising clinical trials extend profitable opportunities to the market players in the forecast period of 2022 to 2027.
Increasing awareness about early detection of breast cancer and the improved reimbursement scenario is expected to further fuel the growth of the market. Furthermore, increasing population, more initiatives by public organizations towards female health problems, and a rise in healthcare expenditure are expected to positively affect the market.
Top Key Players in the Breast Biopsy Devices Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Breast Biopsy Devices Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report include Mammotome, Hologic, C.R Bard, BD, Stryker, Galini SRL, Medtronic, and others.
Global Breast Biopsy Devices Market research provides detailed Analytical Insights of global market size, regional and country-level scope, segmentation wise growth, global share, Competition Scenario, sales analysis, impact global market players on domestic players, value chain optimization, trade regulations, Latest developments, future opportunities, product launches, expanding marketplaces, and New technological innovations.
The breast Biopsy Devices Market is segmented based on the type, applications, companies, and regions.
By Type, Breast Biopsy Devices Market has been segmented into
By Application, Breast Biopsy Devices Market has been segmented into
The report offers an in-depth assessment of the growth and other aspects of the Breast Biopsy Devices Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, and Latin America.
Breast Biopsy Devices Market highlights the potential growth opportunities in upcoming years while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects in the global market. The Global Breast Biopsy Devices Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes
|
Report Details |
Forecast Period 2022 to 2027 CAGR |
CAGR of 8.6% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies
| Mammotome, Hologic, C.R Bard, BD, Stryker, Galini SRL, Medtronic |
Regions Covered
|
|
Countries Covered |
|
Base Year
|
2022 |
Historical Year
|
2017 to 2022 |
Forecast Year
|
2022 to 2027 |
Customization Available
|
Yes, the report can be customized as per your needs |
The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions, Technological Innovations, and Role of Manufacturers during the COVID19 Pandemic. Additionally, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
What is the study period of this market?
The Breast Biopsy Devices Market is studied from 2017 - 2027.
What is the growth rate of Breast Biopsy Devices Market?
The Breast Biopsy Devices Market is growing at a CAGR of 8.6% over the next 5 years.
Who are the key players in Breast Biopsy Devices Market?
Mammotome, Hologic, C.R Bard, BD, Stryker, Galini SRL, Medtronic
What region does this Breast Biopsy Devices Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Breast Biopsy Devices Market?
Biopsy Needles, Biopsy Tables, Guidance Systems, Localization Wires, Others
What are the major end-use applications of Breast Biopsy Devices Market?
Hospital, Clinic
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.
